You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

List of Excipients in API guaifenesin and pseudoephedrine hydrochloride


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing guaifenesin and pseudoephedrine hydrochloride

Glossary

Excipients in ANDA-approved (generic) drugs containing guaifenesin and pseudoephedrine hydrochloride

Detailed excipient profiles for guaifenesin and pseudoephedrine hydrochloride

Excipient focus: ALUMINUM OXIDE

guaifenesin and pseudoephedrine hydrochloride drug variants containing ALUMINUM OXIDE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing ALUMINUM OXIDE

Excipient focus: CARBOMER 934

Excipient focus: CARBOMER HOMOPOLYMER TYPE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing CARBOMER HOMOPOLYMER TYPE

Excipient focus: CARBOMER HOMOPOLYMER TYPE B

guaifenesin and pseudoephedrine hydrochloride drug variants containing CARBOMER HOMOPOLYMER TYPE B

Excipient focus: CELLULOSE, MICROCRYSTALLINE

guaifenesin and pseudoephedrine hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: FD&C YELLOW NO. 6

guaifenesin and pseudoephedrine hydrochloride drug variants containing FD&C YELLOW NO. 6

guaifenesin and pseudoephedrine hydrochloride drug variants not containing FD&C YELLOW NO. 6

Excipient focus: HYPROMELLOSE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing HYPROMELLOSE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: MAGNESIUM STEARATE

guaifenesin and pseudoephedrine hydrochloride drug variants containing MAGNESIUM STEARATE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing MAGNESIUM STEARATE

CompanyIngredientNDC
No data available in table
>Company>Ingredient>NDC

Subscribe to access the full database, or Try for Free

Showing 0 to 0 of 0 entries

Excipient focus: SILICON DIOXIDE

guaifenesin and pseudoephedrine hydrochloride drug variants containing SILICON DIOXIDE

guaifenesin and pseudoephedrine hydrochloride drug variants not containing SILICON DIOXIDE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A

guaifenesin and pseudoephedrine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

guaifenesin and pseudoephedrine hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

guaifenesin and pseudoephedrine hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group